Sandeep K Ganji1,2, Elizabeth A Maher3,4,5,6, Changho Choi1,2,3. 1. Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA. 2. Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA. 3. Harold C. Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA. 4. Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA. 5. Annette Strauss Center for Neuro-Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA. 6. Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Abstract
PURPOSE: MR spectroscopic imaging (SI) of glycine (Gly) in the human brain is challenging due to the interference of the abundant neighboring J-coupled resonances. Our aim is to accomplish reliable imaging of Gly in healthy brain and brain tumors using an optimized MR sequence scheme at 3 tesla. METHODS: Two-dimensional (1)H SI was performed with a point-resolved spectroscopy scheme. An echo time of 160 ms was used for separation between Gly and myo-inositol signals. Data were collected from eight healthy volunteers and 14 subjects with gliomas. Spectra were analyzed with the linear combination model using numerically calculated basis spectra. Metabolite concentrations were estimated with reference to creatine in white matter (WM) regions at 6.4 molar concentrations (mM). RESULTS: From a linear regression analysis with respect to the fractional gray matter (GM) content, the Gly concentrations in pure GM and WM in healthy brains were estimated to be 1.1 and 0.3 mM, respectively. Gly was significantly elevated in tumors. The tumor-to-contralateral Gly concentration ratio was more extensive with higher grades, showing ∼ 10-fold elevation of Gly in glioblastomas. CONCLUSION: The Gly level is significantly different between GM and WM in healthy brains. Our data indicate that SI of Gly may provide a biomarker of brain tumor malignancy.
PURPOSE: MR spectroscopic imaging (SI) of glycine (Gly) in the human brain is challenging due to the interference of the abundant neighboring J-coupled resonances. Our aim is to accomplish reliable imaging of Gly in healthy brain and brain tumors using an optimized MR sequence scheme at 3 tesla. METHODS: Two-dimensional (1)H SI was performed with a point-resolved spectroscopy scheme. An echo time of 160 ms was used for separation between Gly and myo-inositol signals. Data were collected from eight healthy volunteers and 14 subjects with gliomas. Spectra were analyzed with the linear combination model using numerically calculated basis spectra. Metabolite concentrations were estimated with reference to creatine in white matter (WM) regions at 6.4 molar concentrations (mM). RESULTS: From a linear regression analysis with respect to the fractional gray matter (GM) content, the Gly concentrations in pure GM and WM in healthy brains were estimated to be 1.1 and 0.3 mM, respectively. Gly was significantly elevated in tumors. The tumor-to-contralateral Gly concentration ratio was more extensive with higher grades, showing ∼ 10-fold elevation of Gly in glioblastomas. CONCLUSION: The Gly level is significantly different between GM and WM in healthy brains. Our data indicate that SI of Gly may provide a biomarker of brain tumor malignancy.
Authors: Mohit Jain; Roland Nilsson; Sonia Sharma; Nikhil Madhusudhan; Toshimori Kitami; Amanda L Souza; Ran Kafri; Marc W Kirschner; Clary B Clish; Vamsi K Mootha Journal: Science Date: 2012-05-25 Impact factor: 47.728
Authors: Oliver T Wiebenga; Antoine M Klauser; Gijsbert J A Nagtegaal; Menno M Schoonheim; Frederik Barkhof; Jeroen J G Geurts; Petra J W Pouwels Journal: NMR Biomed Date: 2014-01-07 Impact factor: 4.044
Authors: Changho Choi; Paramjit P Bhardwaj; Peter Seres; Sanjay Kalra; Philip G Tibbo; Nicholas J Coupland Journal: Magn Reson Med Date: 2008-01 Impact factor: 4.668
Authors: Vivek Tiwari; Elena V Daoud; Kimmo J Hatanpaa; Ang Gao; Song Zhang; Zhongxu An; Sandeep K Ganji; Jack M Raisanen; Cheryl M Lewis; Pegah Askari; Jeannie Baxter; Michael Levy; Ivan Dimitrov; Binu P Thomas; Marco C Pinho; Christopher J Madden; Edward Pan; Toral R Patel; Ralph J DeBerardinis; A Dean Sherry; Bruce E Mickey; Craig R Malloy; Elizabeth A Maher; Changho Choi Journal: Neuro Oncol Date: 2020-07-07 Impact factor: 12.300
Authors: Vivek Tiwari; Zhongxu An; Sandeep K Ganji; Jeannie Baxter; Toral R Patel; Edward Pan; Bruce E Mickey; Elizabeth A Maher; Marco C Pinho; Changho Choi Journal: NMR Biomed Date: 2017-05-26 Impact factor: 4.044
Authors: D Ito; C Ishikawa; N D Jeffery; K Ono; M Tsuboi; K Uchida; O Yamato; M Kitagawa Journal: J Vet Intern Med Date: 2018-02-25 Impact factor: 3.333
Authors: Gilbert Hangel; Cornelius Cadrien; Philipp Lazen; Julia Furtner; Alexandra Lipka; Eva Hečková; Lukas Hingerl; Stanislav Motyka; Stephan Gruber; Bernhard Strasser; Barbara Kiesel; Mario Mischkulnig; Matthias Preusser; Thomas Roetzer; Adelheid Wöhrer; Georg Widhalm; Karl Rössler; Siegfried Trattnig; Wolfgang Bogner Journal: Neuroimage Clin Date: 2020-09-15 Impact factor: 4.881